Avance Biosciences™ Registers with CLIA, Expanding Clinical Trial Testing Capabilities
HOUSTON, Feb. 26, 2025 /PRNewswire/ -- Avance Biosciences, a leading provider of high-quality analytical and bioanalytical services for the pharmaceutical...
Pharmaceutical
LSPedia Awarded MMCAP Infuse National Contract for FDA DSCSA Compliance
LSPedia's OneScan Suite Transforms Healthcare Operations with Seamless FDA DSCSA Compliance, Integration, and Unmatched Supply Chain Insights. FARMINGTON HILLS, Mich.,...
Compugen Enhances its AI/ML Predictive Computational Discovery Platform, Unigen™ with Ultima Genomics’ Single Cell Genomics Sequencing Technology
Gene structure information identified by combining Compugen's AI/ML predictive computational discovery platform, Unigen™ with Ultima's UG 100™ sequencing platform to better understand...
LiveWorld Expands Board of Directors, Adding Healthcare & Tech Executive Carl Gustin
Marketing innovator Mr. Gustin to drive LiveWorld’s AI-powered growth Carl Gustin, Chief Strategy & Marketing Officer, SpeciCare Carl Gustin appointed...
Rakovina Therapeutics and Variational AI Strengthen Partnership
Strategic Funding Led by Nimbus Synergies, Backed by Merck GHI, to Accelerate AI-Powered CollaborationsVANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE...
Scorpius Holdings Engages Alliance Global Partners to Explore Strategic Alternatives
DURHAM, N.C., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated...
Impact Biomedical Inc. Announces Acquisition of Celios®, “Protecting People, Plants, and Animals from the World’s Most Dangerous Pathogens With Clean-Room Air Quality”
HOUSTON, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering,...
Allarity Therapeutics Announces Dismissal of Securities Class Action Lawsuit
Boston (February 26, 2025)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing...
Korro to Present at the TD Cowen 45th Annual Health Care Conference
CAMBRIDGE, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on...
Aspargo Labs Appoints Mario Guralnik as Chief Regulatory Officer
Accomplished regulatory affairs veteran to lead company’s global regulatory strategy and drug product developmentNEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE)...
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results
Ginkgo provides update on its restructuring process including significant improvement in cash flow in the fourth quarter, completion of site...
emtelligent survey shows healthcare AI users seek tools to unlock more value from unstructured data
VANCOUVER, BC, Feb. 25, 2025 /PRNewswire/ -- AI users in healthcare see significant opportunities in using unstructured data for innovation...
Corundum Systems Biology Expands U.S. Presence with Appointment of Senior Executives
Addition of New Team Members will Bolster Venture Builder's Expertise in Microbiome R&D and Data Science TOKYO, Feb. 25, 2025 /PRNewswire/...
Contura Orthopedics Expands to Canada, Bringing Arthrosamid® to North America
LONDON, Feb. 25, 2025 /PRNewswire/ -- Contura Orthopedics is pleased to announce the launch of Contura Orthopedics (Canada) Ltd., marking a...
Canary Speech Announces Presence Within Microsoft Booth at HIMSS
Strategic partnership with Microsoft provides growth opportunity for Canary Speech, which aims to set new industry standards for managing mental...
Adial Pharmaceuticals Receives Positive Response from FDA Meeting Regarding Proposed In Vitro Bridging Strategy for AD04
FDA feedback confirms Adial’s proposed in vitro bridging strategy to the Phase 3 formulation to fulfill the bridging requirement for...
Alkeus Pharmaceuticals Announces Establishment of Scientific Advisory Board
Preeminent retinal disease expert panel to support Alkeus’ development programs and scienceCAMBRIDGE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Alkeus...
Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Present at the Emergencies in Medicine Conference on Advancing Concussion Treatment
SARASOTA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for...
LIXTE Adds Northwestern University’s Lurie Cancer Center as Second Site in Ongoing Clinical Trial for Ovarian Clear Cell Cancer
-- Lurie Cancer Center Completes Dosing of First Patient with LIXTE’s LB-100 in Combination with GSK’s Immunotherapy Dostarlimab -- PASADENA,...
AlterDiag, a company financially backed by Forepont Capital Partner (FCP), announces the signature of a strategic partnership with the Institut Pasteur on research and development of next generation rapid diagnostic technologies for the diagnosis of infectious diseases
AlterDiag has signed a long-term strategic partnership agreement with the Institut Pasteur for the development of new single-domain antibodies-based rapid...